Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
December 2nd, 2018 : Edge Therapeutics (EDGE) Sees Large Volume Increase
https://www.thecerbatgem.com/2018/12/02/edge-therapeutics-edge-sees-large-volume-increase.html
34.22% of the stock is currently owned by institutional investors.
SQUEEZE probably next week i think. EDGE away multipler now with the R/M and shorts will start big covering latest by possible R/M and pipeline updates next week i think. EDGE for me best way to go multi $ now.
Yes, next week easily get the $1.17 more or less area, than depends squeeze or not, but in any case $5 or $6 could be reached.
EDGE next days above $1. Company cash value alone above $1. see no danger for the continued existence of the NASDAQ listing.
Simple buy ..1500 share will with reverse merger 5 to 1 become 300 shares or 10 for 1 150 shares..either way we will be back on Nasdaz as the stock is worth a dollar a share cash and if the trials prove fruitful after merger they will in crease value wise 10 fold..as time goes on I will watch and add at appropriate times...yes it is a shame that there was a huge sell off..definately a great time to pick shares up at this price..the upside potential is huge...first quarter of 2019..excited about this company...$$$
100% agree with you. EDGE R/M with PDS Biotech is a epic News for all EDGE share holder. 1. Low Floater 2. huge Cash position 3. New Company = New future 4. New Pipeline 5. extremly undervalued 6. many phantasy for positiv future now. EDGE for me very quick by $5 $6 trading range. new revulation start.
Picked up some edge yesterday after briefly doing some research..This company is a winner and to be going with a company that will by end of January bring this stock to a much higher level..there are Millions of cancer patients and future ones to come..Any less invasive treatments will be hailed widely...That we have this golden opportunity to get in at this level I is a miracle in itself..The lawyers have a frivolous case and if anything have caused this stock to go down and injured shareholders...with loss and fear..long term this company could be very successful..they have had revenue coming in for years and there certainly are very few shares out there...tight float and getting tighter.
to short a biotech Company who close a R/M and trading 50% less cash value is not a good idea. SQUEEZE pending + R/M updates + pipeline from new Company... EDGE fast $5 $6 short term imho. extremly undervalued. huge jump ahead.
False!
You must be shorting this
Yes, it crashed because EDGE is an overhyped scam.
I received a promo email out of Berlin...
Instant scam warning.
* * $EDGE Video Chart 11-30-18 * *
Link to Video - click here to watch the technical chart video
EDGE SQUEEZE next week. 6.4m vol.. awesome friday
Multi $ coming. today warm up. next week will be huge. New flow looks like start
Does anyone know why EDGE crashed to $0.518 this early morning? Anyway it soared to $0.72 so far like I predicted yesterday!
Hopefully $0.5051 will be the forever Bottom for us!
it will, will start realy next week with new month coming, actually churming nicely around 0.66 before next leg.
yes alone cash value above $1. now with R/M and new pipeline EDGE fast $5 $6 by next positiv outlook News and Phase 2 News. New company fill EDGE shell with Business. Sounds fantastic. can only go 1 way for me. UP.
$EDGE In last 10-Q : Cash and cash equivalents $ 36,814,899...$1.17/share
Add to this huge gap and ... : )
Took a while but looks like ship is starting to sail back in the right direction.
HUGE EDGE NEWS OUT >> R/M AND PIPELINE INTO NEW FUTURE!! $5 $6 MY FIRST TARGET SHORT TERM!
Edison issues update on NetScientific (NSCI)
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Intraday Stock Chart
Today : Friday 30 November 2018
Click Here for more EDGE THERAPEUTICS, INC. Charts.
In late November 2018, NetScientific (AIM: NSCI) announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will merge. The new entity will trade on the NASDAQ and PDS’s shareholders will maintain majority ownership with a 70% stake, whereas Edge’s shareholders will hold the remaining 30%. The transaction is expected to close in Q119 and NetScientific’s ownership is expected to decrease to 9.2% (from 13.1%). The newly formed entity says it intends to use the combined cash balance of ~$25m to initiate several Phase II clinical trials of its PDS0101 cancer vaccine and to fund operations into 2020.
On 26 November 2018, NetScientific announced that it is interested in exploring strategic alternatives to maximise value for its shareholders. Such approaches include selling the company in its entirety or selling specific holdings in its portfolio of investments. NetScientific is not in discussions with third parties at this time.
Click here to view the full report.
All reports published by Edison are available to download free of charge from its website www.edisoninvestmentresearch.com
About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
Edison is authorised and regulated by the Financial Conduct Authority.
yes EDGE awesome setting now. have double my position this week. looking forward R/M update + new pipeline outlook 2019. think the R/M very huge for EDGE and expect a 1000% turn around like my BCRX EBIO biotech invests some time ago. New company out of shell with new pipeline and new future. sounds fantastic for me.
Wow, EDGE closed at daily high $0.5698 which means $0.6xxx tomorrow and possible $0.71 next Monday! Today's low $0.5109 is higher than yesterday's low $0.5097 and the-day-before-yesterday's low $0.5051 which means higher low everyday!
EDGE +8% going in position for big bounce. R/M and new pipeline updates could kick in anytime. EDGE a 1000% turn around ticket for me. R/M = new future... Radar for big time
Moving forward, the CNA Finance team will continue to keep a close eye on EDGE. In particular, we’re interested in following the story surrounding the company’s merger and how that merger changes the game ahead. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
SQUEEZE could trigger any time. strong bottom has build. EDGE will jump from here imho. EDGE $1 cash value and trading $0.55 range. huge booommmm ahead imho. R/M update and new future pipeline news could come
EDGE going in position!! Big time ahead
zero selling this area. EDGE could start anytime now. tic toc....
welcome on long side. have double my positIon yesterday $0.53/4. Bounce coming. EDGE extremly undervalued oversold after the R/M with new pipeline. expect updates
Yes, now EDGE is a Too-Cheap-To-Miss-Out Huge investing opportunity at Dirt Cheap $0.5xxx price levels! We should see this hidden gem quickly bounce back to the Dollar Land again...
So far it hit $0.56 and we should see $0.68 again as soon as today!
On the day before yesterday it even hit as high as $1.07!
Currently EDGE is Hyper Oversold and Hyper Undervalued! Both Book Value ($0.9891 per share) and Cash Value ($1.1752 per share) are Very High and they are Double of its current ridiculous low price!
EDGE BOUNCE TIME »»» R/M ARE DEFINITIV HUGE FOR EDGE!!! CASH VALUE ALONE $1.
[img]Edge Therapeutics, Inc. (EDGE) Top Holders
Institutional investors currently hold around $7 million or 31.9% in EDGE [/img]stock. Look at its top three institutional owners. Sofinnova Ventures Inc owns $2 million in Edge Therapeutics, Inc.
Hurtin for a squirten
Ok so EDGE ticker symbol is being tossed out because the new company owns 70% of the pie
Ok so u are officially long now?
What's Next
The deal is expected to close in the first quarter of 2019.
Following the consummation of the deal, the merged entity will function under the name PDS Biotechnology Corp., with the shares of the combined company to be listed on the Nasdaq under a new ticker symbol to be announced at a later date.
On the pipeline front, the combined company plans to initiate Phase 2b/3 clinical trials of PDS101 in HPV-associated cancers
Why It's Important
Edge sees the merger as facilitating the creation of a publicly traded immuno-oncology company that develops novel products to treat early- and late-stage cancer.
PDS Biotech's lead candidate PDS101 has demonstrated immunotherapeutic anti-cancer activity and a favorable safety profile in early stage cervical cancer in a Phase 1/2 clinical trial.
"We expect that the combined company will have the financial resources and experienced leadership to accomplish our key near-term objectives: first, to initiate multiple late-stage clinical studies for our lead product candidate PDS0101; and second, to further advance our preclinical programs toward the clinic," PDS CEO Frank Bedu-Addo said in a statement.
What Happened
Edge Therapeutics announced its intention to merge with the privately held, clinical-stage cancer immunotherapy company PDS Biotechnology Corp. The boards of both companies approved the proposed transaction, the companies said in a joint press release.
The reverse merger deal is structured as a stock-for-stock transaction in which all PDS shares would be converted into Edge common stock, with the exchange ratio suggesting that immediately following the merger, PDS shareholders will own about 70 percent of the combined company and existing Edge shareholders will hold the remainder.
A reverse merger deal is a transaction in which an active private company merges with a dormant public company in a bid to go public without having to go through the arduous route of a traditional initial public offering.
Edge announced a comprehensive review of strategic alternatives in April in a bid to maximize shareholder value. The decision followed a failed late-stage trial of its aneurysmal subarachnoid hemorrhages treatment candidate, which subsequently forced the company to announce layoffs.
speak from possible shorted shares from yesterday + today. the R/M is fantastic for EDGE. not wonder if we fly back up coming days.
LOL, only 707,500 shares were shorted as of 11/13/2018! So the Short-Squeezing effect will not be very strong due to just small amount of shorted shares! By the way no any retail investors could short EDGE and only those institutions could short it!
The Pos Scam crashed to Another New 52-week low $0.5229 today after the so-called Merger "Good News"!
Who are those very stupid buyers which bought EDGE at $1.02 ~ $0.68 yesterday? IMO, only those $0.6799 ~ $0.5229 buyers could make some gains in the coming days/weeks...
Anyway $0.5229 seems Final Real Bottom price and not much further space to decline! We might see 30%+ Quick bounce as soon as tomorrow!
not sure. but its a possible reason. the R/M for me a extremly good news for EDGE and the future. thats never a reason for a 50% cut. Short or old EDGE Insider selling i think. expect a big bounce next days. the facts now much better like 3 days ago and the pps from $1 pre to 0.53.
I read that, but even a 30% merger with a good partner would give valuation to EDGE, if the other had assets to match.
Imagine if you had 30% of a big pharma.
Like I was attempting to explain to everyone yesterday as well as today, the stock is down because it had been trading on its cash valuation alone. There was hopes that the company would be bought out or a merger of equals completed. This was no merger of equals. Because shareholders of EDGE have only a 30% ownership now
The merger gives hope to EDGE future with new pipeline.
Why is it down from 0.70 to 0.55 on merger, is the million dollar question.
Normally a merger gives a good spike to share price.
What makes you think that an Insider would sell this in the .50s unless The Insider had Advanced knowledge of something?
You have to admit something to yourself.
You made a mistake. And that's okay
EDGE was a Shell company traded $1 area by Cash value. Since yesterday EDGE not longer a shell. New private company R/M EDGE shell to go public with new Pipeline. sounds fantastic now. facts are great. share price must follow. my opinion
My avg. entry is deeper but yes i am also red now. think not for long time. R/M is great. yesterday a Lot $1 trading vol. pre market. the market say great news but looks like a insider sold out into the great news. if the seller are done we Spike back up big i think. maybe tomorrow we start. loockig forward. EDGE extremly undervslued
You've been "tic tocking" since $1.20
EDGE is now .53
I have to be sincere in stating that he has no idea what he's talking about
epic SQUEEZE tomorrow next days? tic toc......
How do you know it is 50% under cash value after merger?
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1509
|
Created
|
09/30/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |